Ignite Creation Date:
2024-10-25 @ 7:58 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06561620
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-16
Brief Title:
Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients
Sponsor:
Organization:
None